#AMMF2026
Take a look at some of the insights shared from world leading experts highlighted during #AMMF's 2026 European #Cholangiocarcinoma #Conference.

Raising awareness one 💜 at a time.

#bileductcancer #AMMF2026
May 28, 2026 at 9:30 AM
The penultimate session at #AMMF’s 2026 European #Cholangiocarcinoma Conference is Fast Science, co-chaired by #CCA experts Professor Tim Kendall and Professor Kevin Gaston.

Today’s sessions available tomorrow via the platform, register here: ammf.org.uk/ammf-confere... #AMMF2026
May 15, 2026 at 3:25 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 15, 2026 at 11:39 AM
Interesting presentation on investigational breath-based biomarkers being evaluated for potential use in liver cancer detection. Dr Karagiannidis of Imperial College London outlined the underlying technology and ongoing validation work.
#AMMF2026 #Biomarkers #LiverCancer
May 15, 2026 at 11:38 AM
Welcome to Day 3 the final day of #AMMF’s conference! Let's make it count!

You can catch up on Day 1 and Day 2 sessions via our app. To access the app, register via our website: https://ammf.org.uk/ammf-conference-2026/

#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 15, 2026 at 8:00 AM
All AMMF’s sponsors supporting AMMF’s 2026 Conference have provided financial contribution only. They have not been involved in the content or any other aspect of the conference except as exhibitors and attendees.

#AMMF2026 #cholangiocarcinoma #LiverCancer #bileductcancer #CCA
May 15, 2026 at 7:30 AM
As Day 2 of #AMMF’s 2026 European #Cholangiocarcinoma Conference comes to a close, we reflect on an insightful, information-packed day.
Today’s sessions will be available to watch on demand tomorrow. Register for the platform: webapp.spotme.com/login/events...
#AMMF2026 #bileductcancer #CCA
May 14, 2026 at 6:09 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 4:12 PM
“Reliable #biomarkers are crucial for early detection of #CCA.”
In a recorded presentation, Prof. Loilome (Khon Kaen University) shared mass spectrometry-based biomarker research identifying circulating tumour peptide patterns in hepatobiliary cancers. #AMMF2026 #Biomarkers #CancerResearch
May 14, 2026 at 4:12 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 4:05 PM
Prof. Primrose @unisouthampton.bsky.social shared lessons from Thailand’s experience in #CCA #screening and #surgery. A clinical visit showcased a high standard of surgery with excellent operative expertise, alongside a unique prevention and screening programme.
#AMMF2026 #GlobalHealth
May 14, 2026 at 4:04 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 3:53 PM
Spotlight on CCA in Wales - Ms Trish Duncan (University Hospital of Wales) highlighted variation in #care pathways and access across #Wales. #CCA does not currently have a national optimal pathway in Wales. “We need a greater awareness of CCA and improved reporting.”
#AMMF2026
May 14, 2026 at 3:52 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 3:27 PM
“Variation in adherence to best practice guidelines between centres persist.” Ms Jane McClements @belfasttrust.bsky.social presented results from the UK nationwide CAPBIL study evaluating care and outcomes in patients with intrahepatic CCA.
#AMMF2026 #BestPractice #CCA
May 14, 2026 at 3:26 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 2:16 PM
"The complexity of #CCA surgery varies depending on tumour location with perihilar CCA remaining one of the most challenging subtypes to manage." Prof. Primrose (@unisouthampton.bsky.social) explored how surgical management for #CCA continues to evolve.
#AMMF2026 #Surgery #cholangiocarcinoma
May 14, 2026 at 2:16 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 1:54 PM
“There is an urgent need for standardised guidelines for the management of #gallbladder cancer in the UK.” Prof. Gomez @uniofnottingham.bsky.social shared an overview of key recommendations from the British Society of Gastroenterology on #GBC diagnosis and management.
#AMMF2026
May 14, 2026 at 1:54 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 12:59 PM
Prof. Khan from Imperial College Healthcare presented the Asp-PSC trial, an ongoing study investigating whether low-dose aspirin could reduce the risk of primary sclerosing cholangitis (PSC)-associated cancers in patients with #PSC and inflammatory bowel disease (IBD).
#AMMF2026
May 14, 2026 at 12:59 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 12:52 PM
Prof. Hawkins of University College London shared the latest advances and data exploring the potential role of radiotherapy across the treatment landscape for #CCA. “It would be nice to have a biomarker to help determine who should receive radiotherapy, but we are not there yet.”
#AMMF2026
May 14, 2026 at 12:51 PM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 10:29 AM
All posts associated with #AMMF2026 are created independently and have not been influenced by supporters and sponsors.
May 14, 2026 at 10:29 AM